European Journal of Cardio-Thoracic Surgery

Transcription

1 European Journal of Cardio-Thoracic Surgery ejcts.oxfordjournals.org 2013 Media Kit Advertising & Sales Contacts Naomi Reeves Advertising Sales Manager t: +44 (0) e: Caroline Bracken Supplements Development Manager t:+44 (0) e: For reprints, eprints or tailored products: e: The European Journal of Cardio-Thoracic Surgery is the ideal place to reach cardio-thoracic surgeons in Europe and beyond. It is an international journal that accepts submissions from all regions. The journal is supported by a number of leading European societies. A subscription to the journal is a member benefit to the European Society of Thoracic Surgeons and the European Association for Cardio-Thoracic Surgery. Useful Information Print Circulation: 4,800 Geographic Breakdown: UK 4% - Europe 33% - North America 19% - Japan 25% - Rest of World 19% Average Monthly Page Views: 136,066 Average Monthly Unique IPs: 50,000 Average Available Ad Impressions: 270,278* *Combined monthly leaderboard and skyscraper positions Impact Factor: 2.55 Target Audience: Cardio-Thoracic Surgeons Frequency: 12 Peer Reviewed: Yes Editor-In-Chief: Friedhelm Beyersdorf Society Affiliation: European Association for Cardio-Thoracic Surgery European Society of Thoracic Surgeons

2 2013 Schedule Volume Issue Cover Month Ad artwork due Mailout Date Bonus Conference Distribution 43/1 January 22 November December /2 February 19 December January /3 March 22 January February /4 April 25 February March 2013 AATS May Minneapolis 43/5 May 22 March April /6 June 25 April May /1 July 24 May June /2 August 21 June July /3 September 24 July August 2013 EACTS October Vienna 44/14 October 27 August September /5 November 23 September October /6 December 24 October November 2013 STS January Orlando Print Advertising Options & Rates Colour 1 insertion Special Position Premiums Full Page $ ½ Page $ ¼ Page $ Outside Back Cover 50% extra Inside Front Cover 25% extra Inside Back Cover 25% extra Facing Leading Article 10% extra Facing Contents 20% extra

3 European Journal of Cardio-Thoracic Surgery 42 (2012) doi: /ejcts/ezs081 Advance Access publication 5 April 2012 Susan C. van t Westeinde a,b, *, Nanda Horeweg b, Paul De Leyn c, Harry J.M. Groen d, Jan-Willem J. Lammers e, Carla Weenink f, Kristiaan Nackaerts c and Rob J. van Klaveren a a Department of Pulmonology, Erasmus MC Rotterdam, Rotterdam, Netherlands b Department of Public Health, Erasmus MC Rotterdam, Rotterdam, Netherlands c Department of Thoracic Surgery, UZ Gasthuisberg, Leuven, Belgium d Department of Pulmonology, UMC Groningen, Groningen, Netherlands e Department of Pulmonology, UMC Utrecht, Utrecht, Netherlands f Department of Pulmonology, Kennemer Gasthuis Haarlem, Haarlem, Netherlands * Corresponding author. Department of Pulmonology, Erasmus MC, s Gravendijkwal 230, 3015 CE Rotterdam, Netherlands. Tel: ; fax: ; s.vantwesteinde@erasmusmc.nl (S.C. van t Westeinde). Received 15 October 2011; received in revised form 8 January 2012; accepted 10 January 2012 Abstract OBJECTIVES: To assess the complication rate in participants of the screen arm of the NELSON lung cancer screening trial who underwent surgical resection and to investigate, based on a literature review, whether the complication rate, length of hospital stay, rethoracotomy and mortality rates after a surgical procedure were different from those of the non-screening series, taking co-morbidity into account. METHODS: Between April 2004 and December 2008, 198 subjects underwent thoracic surgery. Co-morbid conditions were retrieved from the medical records. Postoperative complications were classified as minor and major. RESULTS: In total, 182 thoracotomies, 5 thoracotomies after video-assisted thoracoscopic surgery (VATS) and 11 VATS procedures were performed. In these patients, 36% had chronic obstructive lung disease, 16% coronary artery disease, 14% diabetes mellitus and 11% peripheral vascular disease. Following thoracotomy, 47% (88/187) had 1 minor (7 57% in literature) and 10% (18/187) 1 major complication (2 26% in literature); following VATS, 38% (6/16) had 1 minor complication, but no major complications. Seventeen per cent (3/18) of major complications and 21% (20/96) of minor complications were seen in subjects operated for benign disease. The rethoracotomy rate was 3% and there was no 30-day mortality after thoracotomy or VATS (0 8.3% in literature). The mortality rate of 0% after surgical procedures is low when compared with the non-screening series (0 8.3%); the rate of complications (53%) is within range when compared with the non-screening series (8.5 58%). CONCLUSIONS: In conclusion, mortality rates after surgical procedures are lower in the NELSON lung cancer screening trial than those in the non-screening series. The rate of complications is within the same range as in the non-screening series. Trial registration number: ISR CTN Keywords: Postoperative complications Thoracotomy Thoracic surgery Video-assisted Early detection of cancer Lung neoplasms INTRODUCTION It has been shown that lung cancer screening by low-dose multidetector computer tomography (CT) can detect lung cancer in a high proportion at an early stage [1]. Before considering implementation of CT screening, a reduction in lung cancer mortality has to be demonstrated by randomized clinical trials and the balance between the benefits and harms of screening has to be evaluated thoroughly. Important aspects to be taken into account are the effect of CT screening on health-related quality of life, and the occurrence of complications associated with the work-up and treatment of participants with a positive test result. Patient-related factors, such as a poor general health status, age and co-morbidity, contribute to the risk of postoperative pulmonary complications [2]. Screening populations usually consist of heavy current and former smokers at an advanced age and at high risk for co-morbid disease. In several studies, it has been shown that co-morbidity can predict morbidity and mortality of surgical procedures [3]. To be able to make a fair comparison with the mortality and complication data reported in non-lung cancer screening series, the co-morbidity of the screen population has to be assessed. Our objective was to assess the complication rate in participants in the screen arm of the Dutch-Belgian lung cancer screening trial (NELSON) who underwent a surgical resection and to investigate, based on a literature review, whether the complication rate, length of stay and The Author Published by Oxford University Press on behalf of the European Association for Cardio-Thoracic Surgery. All rights reserved. ORIGINAL ARTICLE Black & White 1 insertion Full Page $ ½ Page $ ¼ Page $ Incentives Publisher s Discount 10% Agency Commission 10% Double Page Spread = 2 x Full page rate More options and solutions in partnership with European Journal of Cardio-Thoracic Surgery Loose and Bound Inserts available Complications following lung surgery in the Dutch Belgian randomized lung cancer screening trial Belly Band Sponsored supplements published and distributed with the journal Article reprints and eprints useful as conference handouts

4 Online Advertising Options & Rates Advertise on ejcts.oxfordjournals.org Your ad here Online rates Leaderboard Skyscraper Your ad here Type Size (pixels) CPM* Geo-targeted CPM* Leaderboard 728 x 90 42/ 63/$84 50/ 75/$100 Skyscraper 160 x / 75/$100 60/ 90/$120 *Minimum order 10,000 impressions Advertise on table of contents alerts Reach a highly engaged opted in audience etoc Rates & Sizes 325/ 488/$650 per 1000 registrants (min. charge 325/ 488/$650) Banner: 468 x 60 pixels Skyscraper: 160x600 pixels TARGET YOUR AD By country, region, and or therapy area MAXIMUM IMPACT Integrate digital advertising with an ad in the print copy of the journal TRACK RESPONSE In-depth online reports available

5 Print Specifications Size (depth x width) Bleed Trim Type area Full Page 285mm x 222mm 279mm x 216mm 255mm x 178mm Half Page Landscape 120mm x 178mm Half Page Vertical 255mm x 85mm Quarter Page 120mm x 85mm Double Page Spread - Please supply as two separate full page files PDF specifications: PDF files should be created using Adobe Acrobat Distiller 4.0 or higher. Files should be composite PDFs, not separated. All fonts and images should be embedded and subset below 100%. All mono and colour ads should have an effective resolution of 300 dpi (minimum). Colour ads should be supplied as CMYK only (eg no RGB, Lab colour, ICC colour based or Pantone Colour). Monochrome bitmap images (line-art) should have an effective resolution of 1200 dpi. Half-tone dot range should be in the range of 3% to 95%. Ads set to the type area should be surrounded by a box, and have no registration marks or catchlines. Bleed ads should have crop marks set to the trim size dimensions, and will be trimmed accordingly. Please allow 3mm bleed on all four sides. Any vector-based objects with transparency effect must be rasterized to 600 dpi in the source file itself, before creating the PDF. For more information on technical specifications, please contact us. All advertisements are subject to the approval of the Publisher and/or Editor who reserves the right to reject or cancel any advertisement at any time.